PAVmed, Inc. Forecast, price target & analysts
PAVmed, Inc. Target price 2026 - Analyst rating & recommendation
PAVmed, Inc. Classifications & Recommendation
PAVmed, Inc. Price Target
| Target Price | $37.23 |
| Price | $3.97 |
| Potential |
837.78%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target PAVmed, Inc. 2027 .
The average PAVmed, Inc. target price is $37.23.
This is
837.78%
register free of charge
$59.85
1,407.56%
register free of charge
$16.16
307.05%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend PAVmed, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the PAVmed, Inc. stock has an average upside potential 2027 of
837.78%
register free of charge
|
Sales and Margin forecast 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.07 | 0.35 |
| 97.67% | 395.43% | |
| EBITDA Margin | -31,000.00% | -4,294.12% |
| 2,048.30% | 86.15% | |
| Net Margin | -5,385.71% | -5,790.53% |
| 605.38% | 7.52% |
4 Analysts have issued a sales forecast PAVmed, Inc. 2026 . The average PAVmed, Inc. sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an PAVmed, Inc. EBITDA forecast 2026. The average PAVmed, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 PAVmed, Inc. Analysts have issued a net profit forecast 2026. The average PAVmed, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -5.63 | -3.20 |
| 138.35% | 43.16% | |
| P/E | negative | |
| EV/Sales | 123.33 |
4 Analysts have issued a PAVmed, Inc. forecast for earnings per share. The average PAVmed, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Current PAVmed, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Ascendiant Capital |
Locked
➜
Locked
|
Locked | Aug 27 2026 |
| Ascendiant Capital |
Locked
➜
Locked
|
Locked | Jun 08 2026 |
| Ascendiant Capital |
Locked
➜
Locked
|
Locked | Apr 09 2026 |
| Ascendiant Capital |
Locked
➜
Locked
|
Locked | Dec 10 2025 |
| Ascendiant Capital |
Locked
➜
Locked
|
Locked | Oct 06 2025 |
| Ascendiant Capital |
Locked
➜
Locked
|
Locked | Jun 06 2025 |
| Ascendiant Capital |
Locked
➜
Locked
|
Locked | Apr 21 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Ascendiant Capital:
Locked
➜
Locked
|
Aug 27 2026 |
|
Locked
Ascendiant Capital:
Locked
➜
Locked
|
Jun 08 2026 |
|
Locked
Ascendiant Capital:
Locked
➜
Locked
|
Apr 09 2026 |
|
Locked
Ascendiant Capital:
Locked
➜
Locked
|
Dec 10 2025 |
|
Locked
Ascendiant Capital:
Locked
➜
Locked
|
Oct 06 2025 |
|
Locked
Ascendiant Capital:
Locked
➜
Locked
|
Jun 06 2025 |
|
Locked
Ascendiant Capital:
Locked
➜
Locked
|
Apr 21 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
